The Vasopressin V1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies
Year: 2012
Type: article
Study design: Clinical Trial
DOI: 10.4088/jcp.12m07804
Authors: Guy Griebel, Sandra Beeské, Stephen M. Stahl
Institution: Sanofi (France)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2061265867
